You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Colorcon
Dow
Medtronic
Express Scripts

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

DEPO-MEDROL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Depo-medrol patents expire, and when can generic versions of Depo-medrol launch?

Depo-medrol is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in DEPO-MEDROL is methylprednisolone acetate. There are forty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.

Drug patent expirations by year for DEPO-MEDROL
Drug Prices for DEPO-MEDROL

See drug prices for DEPO-MEDROL

Drug Sales Revenue Trends for DEPO-MEDROL

See drug sales revenues for DEPO-MEDROL

Recent Clinical Trials for DEPO-MEDROL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Uppsala University HospitalPhase 2
Uppsala UniversityPhase 2
National Cancer Institute (NCI)Phase 2

See all DEPO-MEDROL clinical trials

Pharmacology for DEPO-MEDROL

US Patents and Regulatory Information for DEPO-MEDROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn DEPO-MEDROL methylprednisolone acetate INJECTABLE;INJECTION 011757-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn DEPO-MEDROL methylprednisolone acetate INJECTABLE;INJECTION 011757-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn DEPO-MEDROL methylprednisolone acetate INJECTABLE;INJECTION 011757-004 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Merck
Baxter
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.